Kolmar Group Chairman Yoon Dong-han Gifts ₩9.8 Billion in Kolmar BNH Shares to Daughter, CEO Yoon Yeo-won

COMPANY / Reporter Kim Jisun / 2025-10-29 03:24:19

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Kim Jisun] SEOUL, October 28, 2025 — Yoon Dong-han, Chairman of Kolmar Group, has gifted his entire shareholding in Kolmar BNH Co., Ltd. to his daughter, Yoon Yeo-won, who serves as the company’s Chief Executive Officer, according to a regulatory filing disclosed on Tuesday.


The filing, submitted to the Financial Supervisory Service (FSS), shows that Chairman Yoon will transfer 692,418 shares — his entire stake — to CEO Yoon on November 28.
The total value of the gifted shares is estimated at ₩9.85 billion (US$7.1 million) based on current market prices.


As a result of the transaction, CEO Yoon’s ownership in Kolmar BNH will rise from 6.54% to 8.89%, an increase of 2.35 percentage points.
The gifted shares include portions that had previously been borrowed and held under her management as part of a share-lending arrangement.


Kolmar BNH’s largest shareholder remains Kolmar Holdings, which owns 44.63% of the company.
Analysts note that the intra-family share transfer will not significantly alter the company’s control structure, as the transaction primarily consolidates holdings within the founding family.


Kolmar BNH, a leading health supplements and beauty materials subsidiary under Kolmar Group, has played a key role in the group’s growth through its functional ingredient R&D and contract manufacturing capabilities.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

IBK Investment & Securities Says Solus Advanced Materials’ Turnaround Delayed to Late 2026 Amid Weak EV Demand
Daehan Steel and Investors File Lawsuit Against Mirae Asset Global Investments Over Alleged Unjust Enrichment
Prosecutors Indict CEO of Seoyoung Holdings for Illegal Loans and Embezzlement Involving NH NongHyup Bank Executive
Shinsegae International Transfers ‘JAJU’ Lifestyle Division to Shinsegae Casa for ₩94 Billion
Kwangdong Pharmaceutical Withdraws Exchangeable Bond Issuance After Financial Regulator Flags “Misleading Disclosure”
뉴스댓글 >

SNS